Differentiating Brain Metastases from Multiple Cerebral Infarcts on MRI
Brain metastases appear as nodular, well-demarcated, contrast-enhancing lesions at the gray-white junction with surrounding vasogenic edema, while subacute infarcts show wedge-like (nonnodular) enhancement involving white matter and overlying cortex with minimal or absent vasogenic edema in the acute phase. 1
Key Distinguishing Features
Lesion Morphology and Location
- Brain metastases: Round or oval, nodular lesions preferentially located at the subcortical gray-white matter junction 1
- Cerebral infarcts: Wedge-shaped configuration following vascular territories, involving both white matter and overlying cortex 1
Enhancement Pattern
- Brain metastases: Solid homogeneous enhancement or ring enhancement (in cystic/necrotic lesions) that is well-demarcated 1
- Subacute infarcts: Enhancement typically begins after the acute phase and follows a gyral pattern; enhancement is nonnodular 1
Surrounding Edema
- Brain metastases: Prominent peritumoral vasogenic edema is commonly present, often disproportionate to lesion size 1
- Acute infarcts: Lack of surrounding vasogenic edema in the acute phase; cytotoxic edema predominates initially 1
Diffusion-Weighted Imaging (DWI)
- Brain metastases: Most show facilitated diffusion (high ADC values), though hypercellular metastases (particularly small-cell lung cancer) can show restricted diffusion 1
- Acute infarcts: Restricted diffusion with low ADC values is the hallmark finding 2
Critical caveat: Some brain metastases, particularly from small-cell lung cancer, can mimic acute infarcts by demonstrating restricted diffusion due to densely cellular histology 1, 2. This overlap can create diagnostic confusion.
Temporal Evolution on Surveillance Imaging
The most reliable distinguishing feature when initial imaging is equivocal is temporal evolution:
- Infarcts: Enhancement regresses over time (weeks to months) 1
- Brain metastases: Enhancement increases with time without effective treatment 1
Recommendation: If the diagnosis remains uncertain after initial imaging, obtain follow-up MRI in 2-4 weeks to assess temporal evolution 1.
Clinical Context Integration
Patient History
- Cancer history: Known primary malignancy (especially lung, breast, melanoma, renal cell carcinoma) strongly favors metastases 1, 3
- Vascular risk factors: Hypertension, diabetes, atrial fibrillation, smoking favor infarcts 4
- Symptom onset: Acute onset (minutes to hours) suggests infarct; subacute progression (days to weeks) suggests metastases 3
Distribution Pattern
- Multiple metastases: Random distribution at gray-white junctions, can be infratentorial (28% of cases) 1, 5
- Multiple infarcts: Follow vascular territories, often bilateral in watershed zones or embolic pattern 4
Rare Mimicry Scenario
Important pitfall: Brain metastases can rarely develop within areas of prior infarction due to neovascularization and blood-brain barrier disruption in infarcted tissue 6, 7. In patients with both cancer and prior stroke, consider metastases if new enhancement develops in a previously infarcted region, particularly if accompanied by new vasogenic edema or mass effect.
Optimal MRI Protocol
For definitive differentiation, ensure the following sequences are obtained:
- T1-weighted pre- and post-gadolinium (preferably 3D volumetric sequences like SPACE, CUBE, or VISTA) 1
- T2-weighted and FLAIR to assess edema pattern 1, 3
- DWI with ADC maps to evaluate diffusion characteristics 1, 3
- Susceptibility-weighted imaging (SWI) or gradient echo (GRE) to detect hemorrhage (common in melanoma, renal, thyroid metastases) 1
Field strength: 3T MRI is superior to 1.5T for detecting small metastases 1